prof. dr. R.E.G. Schutgens
Full Professor
- Hematology/Van Creveldclinic
Contact
Biography
Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. He is Chair of the Blood Transfusion Committee and of the Anticoagulation Committee at the UMC Utrecht and secretary of the Dutch Society for Thrombosis and Haemostasis. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.
Side Activities
Advisory Board Member Horizonscan geneesmiddelen ZonMW since 1-10-2018
Board Member Dutch Society of Haemophilia Treaters since 1-1-2018
Board Member Dutch Society for Thrombosis and Haemostasis since 1-4-2013
Steering Committee Member European ADVANCE working group since 18-12-2008
Research Output (178)
Abnormal coagulation parameters are a common non-neuromuscular feature in patients with spinal muscular atrophy
Wijngaarde Camiel A., Huisman Albert, Wadman Renske I., Cuppen Inge, Stam Marloes, Heitink-Pollé Katja M.J., Groen Ewout J.N., Schutgens Roger E.G., Van Der Pol W. Ludo feb 2020, In: Journal of Neurology, Neurosurgery and Psychiatry. 91 , p. 212-214 3 p.
The Perspectives of Adolescents and Young Adults on Adherence to Prophylaxis in Hemophilia:A Qualitative Study
Hoefnagels J W, Kars M C, Fischer K, Schutgens Reg, Schrijvers L H 23 jan 2020, In: Patient Preference and Adherence. 14 , p. 163-171 9 p.
Congenital platelet disorders and health status-related quality of life
Blaauwgeers Maaike W, Kruip Marieke J H A, Beckers Erik A M, Coppens Michiel, Eikenboom Jeroen, van Galen Karin P M, Tamminga Rienk Y J, Urbanus Rolf T, Schutgens Roger E G, jan 2020, In: Research and practice in thrombosis and haemostasis. 4 , p. 100-105 6 p.
Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease:A systematic review
Punt M. C., Waning M. L., Mauser-Bunschoten E. P., Kruip M. J.H.A., Eikenboom J., Nieuwenhuizen L., Makelburg A. B.U., Driessens M. H.E., Duvekot J. J., Peters M., Middeldorp J. M., Bloemenkamp K. W.M., Schutgens R. E.G., Lely A. T., Van Galen K. P.M. 24 okt 2019, In: Blood Reviews. 39 9 p.
Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease
van der Valk Paul R, Mauser-Bunschoten Eveline P, van der Heijden Jeroen F, Schutgens Roger E G okt 2019, In: TH open : companion journal to thrombosis and haemostasis. 3 , p. e335-e339
Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool
Punt Marieke C, Blaauwgeers Maaike W, Timmer Merel A, Welsing Paco M J, Schutgens Roger E G, van Galen Karin P M okt 2019, In: TH open : companion journal to thrombosis and haemostasis. 3 , p. e350-e355
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P (R)/Humate P (R) treatment in von Willebrand disease patients:Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup>/Humate P<sup>®</sup> treatment in von Willebrand disease patients
de Jager Nico C.B., Bukkems Laura H., Heijdra Jessica M., Hazendonk Carolien H.C.A.M., Fijnvandraat Karin, Meijer Karina, Eikenboom Jeroen, Laros - van Gorkom Britta A.P., Leebeek Frank W.G., Cnossen Marjon H., Mathôt Ron A.A., Collins P. W., Kruip M. J.H.A., Polinder S., Lock J., van Moort I., Goedhart M. C.H.J., Coppens M., Peters M., Preijers T., Brons P., van der Meer F. J.M., Schutgens R. E.G., Fischer K., Driessens M. H.E., Zwaan C. M., van Vliet I., Liesner R., Chowdary P., Keeling D., 26 sep 2019, In: Journal of Thrombosis and Haemostasis. 18 , p. 295-305 11 p.
The Paediatric Haemophilia Activities List (pedHAL) in routine assessment:changes over time, child-parent agreement and informative domains
Kuijlaars Isolde A.R., van der Net Janjaap, Schutgens Roger E.G., Fischer Kathelijn 16 aug 2019, In: Haemophilia. 25 , p. 953-959 7 p.
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
van Galen Karin Pm, Engelen Eveline T, Mauser-Bunschoten Evelien P, van Es Robert JJ, Schutgens Roger EG 19 apr 2019, In: Cochrane Database of Systematic Reviews . 2019
An update on the ‘danger theory’ in inhibitor development in hemophilia A
Schep Sarah J, Boes Marianne L, Schutgens Roger E G, van Vulpen Lize F D 5 apr 2019, In: Expert Review of Hematology. 12 , p. 335-344 10 p.